| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.736 | 0.001 | 0.736 | Glutamate release inhibitor | 0.53 0.001 DBMET01737 0.516 0.001 DBMET01738 0.451 0.002 DBMET01739 0.355 0.003 DBMET01740 | ||
| 0.683 | 0.004 | 0.683 | Growth factor agonist | 0.516 0.004 DBMET01737 0.596 0.004 DBMET01738 0.545 0.004 DBMET01739 0.286 0.019 DBMET01740 | ||
| 0.469 | 0.004 | 0.469 | Nav1.6 sodium channel blocker | 0.296 0.006 DBMET01737 0.284 0.007 DBMET01738 0.249 0.009 DBMET01739 0.17 0.035 DBMET01740 | ||
| 0.436 | 0.018 | 0.603 | Anticonvulsant | 0.211 0.075 DBMET01737 0.211 0.075 DBMET01738 0.182 0.097 DBMET01739 0.603 0.007 DBMET01740 | DBMET01740 | |
| 0.403 | 0.025 | 0.438 | Dyrk kinase inhibitor | 0.294 0.055 DBMET01737 0.438 0.02 DBMET01738 0.247 0.073 DBMET01739 | DBMET01738 | |
| 0.385 | 0.007 | 0.385 | Protein kinase (CK1) delta inhibitor | 0.173 0.04 DBMET01737 0.241 0.018 DBMET01738 0.14 0.059 DBMET01739 0.148 0.054 DBMET01740 | ||
| 0.4 | 0.025 | 0.448 | Dual specificity tyrosine-phosphorylation regulated kinase 1A inhibitor | 0.298 0.051 DBMET01737 0.448 0.019 DBMET01738 0.244 0.07 DBMET01739 | DBMET01738 | |
| 0.4 | 0.028 | 0.507 | Antiamyloidogenic | 0.452 0.021 DBMET01737 0.507 0.015 DBMET01738 0.292 0.054 DBMET01739 | DBMET01738 | |
| 0.37 | 0.007 | 0.37 | Protein-tyrosine kinase (PTK, not ETK, WZC) inhibitor | 0.243 0.018 DBMET01737 0.281 0.013 DBMET01738 0.259 0.016 DBMET01739 0.147 0.049 DBMET01740 | ||
| 0.37 | 0.007 | 0.37 | Abl kinase inhibitor | 0.242 0.018 DBMET01737 0.279 0.014 DBMET01738 0.258 0.016 DBMET01739 0.146 0.049 DBMET01740 | ||
| 0.388 | 0.04 | 0.388 | Aryl hydrocarbon receptor agonist | 0.242 0.082 DBMET01737 0.355 0.047 DBMET01738 0.286 0.065 DBMET01739 0.157 0.13 DBMET01740 | ||
| 0.392 | 0.047 | 0.459 | Caspase 3 stimulant | 0.405 0.043 DBMET01737 0.459 0.027 DBMET01738 0.31 0.074 DBMET01739 0.294 0.082 DBMET01740 | DBMET01738 | |
| 0.415 | 0.07 | 0.502 | Antibacterial | 0.502 0.04 DBMET01737 0.48 0.047 DBMET01738 0.384 0.084 DBMET01739 | DBMET01737 | |
| 0.336 | 0.011 | 0.336 | Nav1.2 sodium channel blocker | 0.185 0.04 DBMET01737 0.204 0.033 DBMET01738 0.165 0.049 DBMET01739 | ||
| 0.418 | 0.101 | 0.501 | Caspase 9 stimulant | 0.371 0.129 DBMET01737 0.501 0.059 DBMET01738 0.315 0.177 DBMET01739 0.384 0.121 DBMET01740 | DBMET01738 | |
| 0.311 | 0.005 | 0.311 | Beta amyloid protein antagonist | 0.202 0.016 DBMET01737 0.294 0.006 DBMET01738 0.19 0.02 DBMET01739 | ||
| 0.303 | 0.005 | 0.323 | Mannose-6-phosphate isomerase inhibitor | 0.29 0.006 DBMET01737 0.323 0.004 DBMET01738 0.251 0.012 DBMET01739 0.176 0.045 DBMET01740 | DBMET01738 | |
| 0.305 | 0.009 | 0.327 | Cell wall synthesis inhibitor | 0.278 0.012 DBMET01737 0.327 0.009 DBMET01738 0.26 0.014 DBMET01739 0.15 0.065 DBMET01740 | DBMET01738 | |
| 0.302 | 0.008 | 0.302 | Nav1.1 sodium channel blocker | 0.219 0.016 DBMET01737 0.221 0.015 DBMET01738 0.19 0.021 DBMET01739 0.105 0.061 DBMET01740 | ||
| 0.31 | 0.034 | 0.31 | Ca(v)3.3 blocker | 0.231 0.132 DBMET01737 0.241 0.115 DBMET01738 0.267 0.077 DBMET01739 0.247 0.106 DBMET01740 | ||
| 0.373 | 0.107 | 0.373 | Cyclophilin D inhibitor | 0.371 0.108 DBMET01737 0.372 0.108 DBMET01738 0.266 0.195 DBMET01739 | ||
| 0.28 | 0.02 | 0.28 | Protein kinase (CK1) inhibitor | 0.118 0.093 DBMET01737 0.189 0.044 DBMET01738 | ||
| 0.327 | 0.069 | 0.459 | Streptokinase A inhibitor | 0.459 0.034 DBMET01737 0.334 0.067 DBMET01738 0.256 0.1 DBMET01739 | DBMET01737 | |
| 0.265 | 0.009 | 0.34 | Catenin beta inhibitor | 0.34 0.005 DBMET01737 0.245 0.012 DBMET01738 0.222 0.019 DBMET01739 0.236 0.014 DBMET01740 | DBMET01737 | |
| 0.268 | 0.023 | 0.309 | NOS3 expression enhancer | 0.248 0.027 DBMET01737 0.309 0.016 DBMET01738 0.167 0.058 DBMET01739 0.18 0.05 DBMET01740 | DBMET01738 | |
| 0.241 | 0.008 | 0.25 | CF transmembrane conductance regulator agonist | 0.25 0.006 DBMET01737 0.209 0.017 DBMET01738 0.249 0.006 DBMET01739 0.162 0.057 DBMET01740 | DBMET01737 | |
| 0.234 | 0.009 | 0.234 | Nav1.5 sodium channel blocker | 0.142 0.032 DBMET01737 0.16 0.022 DBMET01738 0.127 0.047 DBMET01739 | ||
| 0.273 | 0.058 | 0.273 | Potassium channel (Voltage-sensitive) blocker | 0.218 0.084 DBMET01739 | ||
| 0.214 | 0.005 | 0.214 | CDK3/cyclin E inhibitor | 0.178 0.013 DBMET01737 0.196 0.007 DBMET01738 0.2 0.006 DBMET01739 0.194 0.008 DBMET01740 | ||
| 0.211 | 0.009 | 0.211 | CDK2/cyclin E2 inhibitor | 0.087 0.034 DBMET01737 0.139 0.019 DBMET01738 0.148 0.017 DBMET01739 0.072 0.046 DBMET01740 | ||
| 0.209 | 0.008 | 0.209 | Potassium channel activator | 0.19 0.01 DBMET01737 0.167 0.015 DBMET01738 0.108 0.04 DBMET01739 0.095 0.054 DBMET01740 | ||
| 0.21 | 0.013 | 0.263 | Potassium channel (Ca-activated) activator | 0.263 0.007 DBMET01737 0.185 0.018 DBMET01738 0.197 0.015 DBMET01739 | DBMET01737 | |
| 0.256 | 0.064 | 0.256 | HERG channel blocker | 0.238 0.071 DBMET01739 | ||
| 0.253 | 0.061 | 0.253 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.199 0.169 DBMET01738 0.21 0.138 DBMET01739 | ||
| 0.2 | 0.01 | 0.2 | Stem cell growth factor agonist | 0.111 0.036 DBMET01737 0.134 0.025 DBMET01738 0.115 0.034 DBMET01739 0.099 0.046 DBMET01740 | ||
| 0.194 | 0.008 | 0.194 | Nav1.8 sodium channel blocker | 0.106 0.026 DBMET01737 0.111 0.024 DBMET01738 0.134 0.017 DBMET01739 0.081 0.041 DBMET01740 | ||
| 0.285 | 0.105 | 0.324 | Vasodilator, peripheral | 0.307 0.094 DBMET01737 0.324 0.085 DBMET01738 0.214 0.16 DBMET01739 | DBMET01738 | |
| 0.181 | 0.002 | 0.181 | Potassium channel small-conductance Ca-activated activator | 0.084 0.005 DBMET01737 0.094 0.004 DBMET01738 0.09 0.005 DBMET01739 0.075 0.006 DBMET01740 | ||
| 0.2 | 0.025 | 0.2 | Nav1.3 sodium channel blocker | 0.12 0.074 DBMET01737 0.103 0.094 DBMET01738 0.115 0.079 DBMET01739 | ||
| 0.207 | 0.032 | 0.207 | CDC-like kinase 1 inhibitor | 0.142 0.076 DBMET01737 0.182 0.046 DBMET01738 | ||
| 0.202 | 0.029 | 0.202 | Sodium channel (voltage-gated) blocker | |||
| 0.179 | 0.007 | 0.179 | Potassium channel (Voltage-sensitive) activator | 0.133 0.021 DBMET01737 0.118 0.033 DBMET01738 0.089 0.07 DBMET01739 0.103 0.049 DBMET01740 | ||
| 0.172 | 0.006 | 0.172 | Phosphatidylinositol 3-kinase beta inhibitor | 0.075 0.018 DBMET01737 0.118 0.01 DBMET01738 0.144 0.008 DBMET01739 | ||
| 0.287 | 0.125 | 0.287 | GABA C receptor rho-3 antagonist | 0.268 0.139 DBMET01737 0.229 0.174 DBMET01738 0.257 0.148 DBMET01739 | ||
| 0.192 | 0.035 | 0.192 | Sodium channel blocker | |||
| 0.264 | 0.116 | 0.271 | Cholesterol antagonist | 0.218 0.149 DBMET01737 0.271 0.11 DBMET01738 0.211 0.155 DBMET01739 | DBMET01738 | |
| 0.217 | 0.073 | 0.283 | Pyruvate kinase inhibitor | 0.237 0.065 DBMET01737 0.283 0.052 DBMET01738 0.234 0.066 DBMET01739 | DBMET01738 | |
| 0.166 | 0.023 | 0.251 | Carbonic anhydrase III inhibitor | 0.172 0.022 DBMET01737 0.251 0.009 DBMET01738 0.155 0.027 DBMET01739 0.09 0.075 DBMET01740 | DBMET01738 | |
| 0.191 | 0.05 | 0.191 | Polo-like kinase-3 inhibitor | 0.127 0.114 DBMET01737 0.186 0.054 DBMET01738 0.142 0.094 DBMET01739 | ||
| 0.163 | 0.023 | 0.163 | Pim-1 kinase inhibitor | 0.118 0.044 DBMET01737 0.126 0.038 DBMET01738 0.131 0.036 DBMET01739 | ||
| 0.247 | 0.111 | 0.35 | Nootropic | 0.35 0.054 DBMET01737 | DBMET01737 | |
| 0.163 | 0.026 | 0.175 | Carbonic anhydrase XV inhibitor | 0.147 0.032 DBMET01737 0.175 0.023 DBMET01738 0.113 0.053 DBMET01739 | DBMET01738 | |
| 0.155 | 0.02 | 0.155 | Nitric-oxide synthase inhibitor | 0.1 0.059 DBMET01737 0.123 0.036 DBMET01738 0.101 0.058 DBMET01739 | ||
| 0.166 | 0.039 | 0.166 | Sphingosine 1-phosphate receptor 5 antagonist | 0.161 0.045 DBMET01737 0.153 0.057 DBMET01738 0.126 0.11 DBMET01739 | ||
| 0.137 | 0.015 | 0.137 | CDK2/cyclin E inhibitor | 0.059 0.044 DBMET01737 0.094 0.025 DBMET01738 0.057 0.046 DBMET01739 | ||
| 0.123 | 0.005 | 0.123 | Nicotinic acid receptor 1 agonist | 0.058 0.017 DBMET01737 0.072 0.013 DBMET01738 0.06 0.016 DBMET01739 0.051 0.019 DBMET01740 | ||
| 0.13 | 0.016 | 0.13 | Histamine H2 receptor antagonist | 0.076 0.074 DBMET01737 0.081 0.063 DBMET01738 0.079 0.067 DBMET01739 | ||
| 0.137 | 0.03 | 0.171 | DOPA decarboxylase inhibitor | 0.169 0.013 DBMET01737 0.171 0.013 DBMET01738 0.166 0.014 DBMET01739 | DBMET01738 | |
| 0.114 | 0.008 | 0.123 | 3(or 17)beta-hydroxysteroid dehydrogenase inhibitor | 0.103 0.01 DBMET01737 0.123 0.007 DBMET01738 0.099 0.01 DBMET01739 0.077 0.017 DBMET01740 | DBMET01738 | |
| 0.19 | 0.084 | 0.19 | Ca2+/calmodulin-dependent kinase II beta inhibitor | 0.186 0.088 DBMET01738 0.151 0.127 DBMET01739 | ||
| 0.21 | 0.104 | 0.243 | Hypoglycemic | 0.22 0.096 DBMET01737 0.243 0.081 DBMET01738 | DBMET01738 | |
| 0.113 | 0.009 | 0.134 | GABA B receptor agonist | 0.113 0.01 DBMET01737 0.132 0.005 DBMET01738 0.134 0.005 DBMET01739 | DBMET01739 | |
| 0.155 | 0.051 | 0.234 | NADPH oxidase inhibitor | 0.116 0.088 DBMET01737 0.234 0.025 DBMET01738 | DBMET01738 | |
| 0.105 | 0.004 | 0.11 | Fructose-1,6-bisphosphatase inhibitor | 0.1 0.004 DBMET01737 0.11 0.004 DBMET01738 0.091 0.005 DBMET01739 | DBMET01738 | |
| 0.109 | 0.009 | 0.114 | Glutamate (mGluR group III) agonist | 0.064 0.017 DBMET01737 0.114 0.008 DBMET01738 0.103 0.009 DBMET01739 | DBMET01738 | |
| 0.108 | 0.009 | 0.122 | Plasminogen activator inhibitor antagonist | 0.112 0.008 DBMET01737 0.122 0.007 DBMET01738 0.058 0.025 DBMET01739 0.055 0.028 DBMET01740 | DBMET01738 | |
| 0.148 | 0.05 | 0.161 | Heat shock protein 70 antagonist | 0.161 0.027 DBMET01737 0.152 0.04 DBMET01738 0.142 0.067 DBMET01739 | DBMET01737 | |
| 0.106 | 0.009 | 0.106 | Purinergic P2Y antagonist | 0.095 0.01 DBMET01737 0.073 0.014 DBMET01738 0.052 0.025 DBMET01739 | ||
| 0.102 | 0.006 | 0.102 | MAP kinase 7 inhibitor | 0.088 0.024 DBMET01737 0.098 0.009 DBMET01738 0.094 0.013 DBMET01739 0.086 0.026 DBMET01740 | ||
| 0.254 | 0.162 | 0.392 | 15-Lipoxygenase inhibitor | 0.392 0.078 DBMET01737 0.345 0.102 DBMET01738 0.244 0.17 DBMET01739 | DBMET01737 | |
| 0.1 | 0.008 | 0.1 | Cyclin H inhibitor | 0.077 0.022 DBMET01737 0.087 0.014 DBMET01738 0.089 0.012 DBMET01739 | ||
| 0.184 | 0.096 | 0.184 | 5 Hydroxytryptamine 3E antagonist | |||
| 0.107 | 0.022 | 0.121 | D-Ala-D-Ala ligase inhibitor | 0.121 0.013 DBMET01737 0.112 0.018 DBMET01738 0.118 0.015 DBMET01739 0.078 0.074 DBMET01740 | DBMET01737 | |
| 0.149 | 0.065 | 0.225 | Amylase inhibitor | 0.154 0.062 DBMET01737 0.225 0.036 DBMET01738 0.118 0.083 DBMET01739 | DBMET01738 | |
| 0.261 | 0.179 | 0.273 | Transcription factor inhibitor | 0.273 0.171 DBMET01737 | DBMET01737 | |
| 0.19 | 0.11 | 0.278 | Aldehyde oxidase inhibitor | 0.178 0.117 DBMET01737 0.278 0.073 DBMET01738 0.151 0.138 DBMET01739 | DBMET01738 | |
| 0.127 | 0.047 | 0.127 | Nav1.4 sodium channel blocker | 0.111 0.061 DBMET01737 0.114 0.058 DBMET01738 0.122 0.05 DBMET01739 | ||
| 0.189 | 0.11 | 0.202 | Nitric-oxide synthase stimulant | 0.201 0.088 DBMET01737 0.202 0.085 DBMET01738 0.179 0.13 DBMET01739 | DBMET01738 | |
| 0.093 | 0.016 | 0.093 | Orexin receptor antagonist | |||
| 0.181 | 0.105 | 0.181 | Potassium channel blocker | |||
| 0.093 | 0.017 | 0.093 | Neuropeptide Y5 antagonist | |||
| 0.096 | 0.023 | 0.096 | Transforming growth factor antagonist | 0.073 0.043 DBMET01738 0.068 0.052 DBMET01739 | ||
| 0.109 | 0.037 | 0.115 | Polo-like kinase-1 inhibitor | 0.115 0.033 DBMET01738 | DBMET01738 | |
| 0.089 | 0.021 | 0.122 | Purinergic P2X1 antagonist | 0.122 0.011 DBMET01737 0.09 0.02 DBMET01738 0.11 0.014 DBMET01739 | DBMET01737 | |
| 0.162 | 0.094 | 0.243 | Platelet adhesion inhibitor | 0.243 0.052 DBMET01737 0.221 0.061 DBMET01738 | DBMET01737 | |
| 0.075 | 0.009 | 0.075 | CDK7/cyclin H inhibitor | 0.045 0.032 DBMET01737 0.059 0.016 DBMET01738 0.062 0.015 DBMET01739 | ||
| 0.077 | 0.012 | 0.077 | Stearoyl-CoA desaturase inhibitor | 0.04 0.038 DBMET01738 | ||
| 0.067 | 0.003 | 0.067 | Fructose-1,6-bisphosphatase 1 inhibitor | 0.063 0.003 DBMET01737 0.067 0.003 DBMET01738 0.054 0.004 DBMET01739 | ||
| 0.089 | 0.026 | 0.089 | Secretase beta inhibitor | 0.065 0.059 DBMET01737 0.065 0.059 DBMET01738 | ||
| 0.115 | 0.054 | 0.138 | AMP-activated protein kinase stimulant | 0.138 0.036 DBMET01737 0.132 0.04 DBMET01738 0.1 0.07 DBMET01739 | DBMET01737 | |
| 0.156 | 0.096 | 0.156 | TRKC antagonist | 0.135 0.115 DBMET01738 | ||
| 0.099 | 0.04 | 0.099 | TIE-2 antagonist | 0.073 0.065 DBMET01738 | ||
| 0.063 | 0.004 | 0.063 | Vanilloid 3 antagonist | 0.043 0.016 DBMET01737 0.056 0.005 DBMET01738 0.063 0.004 DBMET01739 0.045 0.013 DBMET01740 | ||
| 0.062 | 0.003 | 0.078 | Purinergic P2Y1 antagonist | 0.078 0.003 DBMET01737 0.045 0.004 DBMET01738 0.039 0.004 DBMET01739 0.038 0.004 DBMET01740 | DBMET01737 | |
| 0.134 | 0.076 | 0.134 | Lck kinase inhibitor | 0.125 0.081 DBMET01738 | ||
| 0.104 | 0.046 | 0.104 | Ca(v)2.2 blocker | |||
| 0.094 | 0.036 | 0.094 | Thioredoxin reductase inhibitor | 0.084 0.052 DBMET01737 0.091 0.038 DBMET01738 0.079 0.066 DBMET01739 | ||
| 0.078 | 0.021 | 0.078 | Phosphatidylinositol 3-kinase gamma inhibitor | 0.054 0.039 DBMET01737 0.064 0.029 DBMET01738 0.071 0.024 DBMET01739 | ||
| 0.069 | 0.011 | 0.069 | Dopamine D3 agonist | 0.057 0.015 DBMET01737 0.053 0.017 DBMET01738 0.049 0.02 DBMET01739 | ||
| 0.099 | 0.042 | 0.099 | TIE antagonist | 0.072 0.068 DBMET01738 | ||
| 0.062 | 0.007 | 0.062 | Endothelial nitric-oxide synthase inhibitor | |||
| 0.169 | 0.115 | 0.173 | Histone acetyltransferase inhibitor | 0.173 0.109 DBMET01738 0.151 0.138 DBMET01739 | DBMET01738 | |
| 0.097 | 0.043 | 0.097 | Bcr-Abl kinase inhibitor | 0.074 0.073 DBMET01738 | ||
| 0.136 | 0.082 | 0.136 | Protein kinase (CK1) gamma 1 inhibitor | 0.111 0.109 DBMET01738 | ||
| 0.071 | 0.019 | 0.071 | Transforming growth factor beta 1 antagonist | 0.053 0.031 DBMET01738 0.047 0.037 DBMET01739 | ||
| 0.054 | 0.005 | 0.054 | Calcium-sensing receptor agonist | 0.031 0.012 DBMET01737 0.028 0.015 DBMET01738 0.028 0.016 DBMET01740 | ||
| 0.059 | 0.011 | 0.059 | Delayed rectifier potassium channel activator | |||
| 0.059 | 0.011 | 0.059 | Potassium channel KCNQ activator | |||
| 0.059 | 0.011 | 0.059 | Dihydrofolate reductase inhibitor | 0.041 0.037 DBMET01737 0.047 0.023 DBMET01738 0.048 0.021 DBMET01739 | ||
| 0.158 | 0.111 | 0.165 | I kappa B kinase epsilon inhibitor | 0.165 0.104 DBMET01738 0.137 0.134 DBMET01739 | DBMET01738 | |
| 0.067 | 0.022 | 0.076 | Factor IXa inhibitor | 0.076 0.017 DBMET01737 0.053 0.034 DBMET01738 | DBMET01737 | |
| 0.105 | 0.06 | 0.105 | Gastric antisecretory | 0.092 0.076 DBMET01737 0.09 0.079 DBMET01738 | ||
| 0.078 | 0.033 | 0.078 | Cyclin E inhibitor | |||
| 0.1 | 0.056 | 0.1 | Lanosterol 14 alpha demethylase inhibitor | |||
| 0.142 | 0.099 | 0.142 | Protein kinase (CK1) gamma 3 inhibitor | 0.129 0.115 DBMET01738 | ||
| 0.071 | 0.028 | 0.071 | Cyclin E1 inhibitor | |||
| 0.145 | 0.103 | 0.145 | LIM domain kinase 1 inhibitor | |||
| 0.08 | 0.039 | 0.093 | CDK1/cyclin B1 inhibitor | 0.071 0.047 DBMET01738 0.093 0.031 DBMET01739 | DBMET01739 | |
| 0.1 | 0.063 | 0.106 | mTOR complex 1 inhibitor | 0.091 0.085 DBMET01738 0.106 0.05 DBMET01739 | DBMET01739 | |
| 0.076 | 0.04 | 0.076 | Orexin receptor 1 antagonist | |||
| 0.07 | 0.034 | 0.07 | Phosphatidylinositol kinase inhibitor | |||
| 0.1 | 0.064 | 0.131 | Protein kinase (CK2) inhibitor | 0.082 0.081 DBMET01737 0.131 0.042 DBMET01738 0.109 0.056 DBMET01739 | DBMET01738 | |
| 0.098 | 0.063 | 0.098 | Glutamate (mGluR7) agonist | |||
| 0.07 | 0.034 | 0.079 | Protease activated receptor antagonist | 0.079 0.024 DBMET01737 | DBMET01737 | |
| 0.149 | 0.115 | 0.149 | Clk dual-specificity kinase inhibitor | |||
| 0.081 | 0.046 | 0.085 | Vanilloid antagonist | 0.066 0.061 DBMET01737 0.085 0.044 DBMET01738 | DBMET01738 | |
| 0.118 | 0.084 | 0.126 | Antibacterial (Helicobacter pylori) | 0.126 0.072 DBMET01738 | DBMET01738 | |
| 0.063 | 0.029 | 0.07 | NMDA 2B receptor antagonist | 0.07 0.025 DBMET01737 0.067 0.027 DBMET01738 0.05 0.044 DBMET01739 | DBMET01737 | |
| 0.074 | 0.041 | 0.074 | Sphingosine 1-phosphate receptor 4 agonist | |||
| 0.057 | 0.024 | 0.057 | Potassium channel (Inward rectifier) activator | |||
| 0.139 | 0.107 | 0.273 | Dual specificity phosphatase 3 inhibitor | 0.273 0.034 DBMET01737 0.2 0.061 DBMET01738 0.151 0.096 DBMET01739 | DBMET01737 | |
| 0.059 | 0.027 | 0.059 | Diacylglycerol O-acyltransferase inhibitor | |||
| 0.047 | 0.016 | 0.047 | Farnesoid X receptor agonist | 0.04 0.024 DBMET01737 | ||
| 0.054 | 0.023 | 0.054 | Potassium channel (ATP-sensitive) activator | |||
| 0.098 | 0.068 | 0.098 | Hedgehog signaling inhibitor | |||
| 0.071 | 0.043 | 0.071 | Nav1.7 sodium channel blocker | |||
| 0.047 | 0.019 | 0.047 | Growth hormone secretagogue receptor agonist | |||
| 0.119 | 0.091 | 0.119 | Protein kinase (CK1) gamma inhibitor | |||
| 0.117 | 0.09 | 0.157 | Alkaline phosphatase inhibitor | 0.139 0.068 DBMET01737 0.136 0.07 DBMET01738 0.157 0.056 DBMET01739 | DBMET01739 | |
| 0.036 | 0.009 | 0.068 | CXC chemokine 2 receptor antagonist | 0.068 0.004 DBMET01737 0.044 0.007 DBMET01738 0.048 0.006 DBMET01739 | DBMET01737 | |
| 0.07 | 0.044 | 0.194 | Dopamine agonist | 0.11 0.023 DBMET01737 0.11 0.023 DBMET01738 0.194 0.01 DBMET01739 | DBMET01739 | |
| 0.107 | 0.081 | 0.136 | Estrogen antagonist | 0.136 0.031 DBMET01737 0.132 0.036 DBMET01738 0.1 0.098 DBMET01740 | DBMET01737 | |
| 0.069 | 0.044 | 0.069 | Acetylcholine M5 receptor agonist | |||
| 0.062 | 0.037 | 0.062 | CDK4/cyclin D1 inhibitor | 0.053 0.045 DBMET01737 0.06 0.038 DBMET01738 | ||
| 0.102 | 0.08 | 0.102 | Aurora-B kinase inhibitor | |||
| 0.077 | 0.056 | 0.077 | Glutamate receptor agonist | |||
| 0.042 | 0.021 | 0.042 | Protein kinase (CK1) epsilon inhibitor | |||
| 0.041 | 0.02 | 0.062 | Estradiol 17 beta-dehydrogenase 2 inhibitor | 0.05 0.016 DBMET01737 0.062 0.01 DBMET01738 0.034 0.025 DBMET01739 | DBMET01738 | |
| 0.128 | 0.108 | 0.128 | Ca2+/calmodulin-dependent kinase II gamma inhibitor | 0.123 0.113 DBMET01738 | ||
| 0.055 | 0.036 | 0.065 | DNA helicase inhibitor | 0.061 0.026 DBMET01737 0.065 0.021 DBMET01738 0.065 0.021 DBMET01739 | DBMET01739 | |
| 0.091 | 0.073 | 0.091 | Cyclin-dependent kinase 9 inhibitor | 0.086 0.082 DBMET01738 | ||
| 0.052 | 0.034 | 0.053 | H+/K+-transporting ATPase inhibitor | 0.053 0.033 DBMET01737 | DBMET01737 | |
| 0.222 | 0.205 | 0.344 | Alpha-glucosidase inhibitor | 0.322 0.149 DBMET01737 0.304 0.158 DBMET01738 0.344 0.138 DBMET01740 | DBMET01740 | |
| 0.065 | 0.048 | 0.076 | Carbonic anhydrase V inhibitor | 0.076 0.038 DBMET01738 | DBMET01738 | |
| 0.07 | 0.054 | 0.082 | Lipase inhibitor | 0.082 0.04 DBMET01738 | DBMET01738 | |
| 0.077 | 0.061 | 0.109 | Carbonic anhydrase VI inhibitor | 0.076 0.062 DBMET01737 0.109 0.034 DBMET01738 0.072 0.069 DBMET01739 | DBMET01738 | |
| 0.038 | 0.022 | 0.038 | Nicotinic acid receptor agonist | |||
| 0.057 | 0.043 | 0.057 | CDK9/cyclin T1 inhibitor | |||
| 0.079 | 0.064 | 0.079 | Inducible nitric-oxide synthase inhibitor | |||
| 0.027 | 0.013 | 0.051 | Estradiol 17 beta-dehydrogenase 1 inhibitor | 0.03 0.011 DBMET01737 0.051 0.007 DBMET01738 0.023 0.015 DBMET01739 | DBMET01738 | |
| 0.039 | 0.025 | 0.039 | TRPM8 blocker | |||
| 0.035 | 0.021 | 0.035 | Peroxisome proliferator-activated receptor delta agonist | |||
| 0.061 | 0.047 | 0.062 | Prolactin release inhibitor | 0.061 0.05 DBMET01738 0.062 0.043 DBMET01739 | DBMET01739 | |
| 0.035 | 0.022 | 0.035 | Glutamate (mGluR4) agonist | 0.033 0.025 DBMET01738 0.033 0.026 DBMET01739 | ||
| 0.044 | 0.031 | 0.086 | Dopamine D2 agonist | 0.086 0.013 DBMET01737 0.079 0.014 DBMET01738 0.046 0.03 DBMET01739 | DBMET01737 | |
| 0.116 | 0.104 | 0.211 | Peroxidase inhibitor | 0.166 0.07 DBMET01737 0.179 0.066 DBMET01738 0.211 0.056 DBMET01739 0.112 0.109 DBMET01740 | DBMET01739 | |
| 0.08 | 0.067 | 0.091 | Myeloperoxidase inhibitor | 0.077 0.073 DBMET01737 0.091 0.047 DBMET01738 0.088 0.052 DBMET01739 | DBMET01738 | |
| 0.054 | 0.043 | 0.058 | Phosphatidylinositol 3-kinase delta inhibitor | 0.058 0.039 DBMET01739 | DBMET01739 | |
| 0.056 | 0.044 | 0.056 | CDK4/cyclin D inhibitor | 0.052 0.051 DBMET01738 | ||
| 0.015 | 0.005 | 0.016 | Thrombopoietin agonist | 0.016 0.005 DBMET01737 0.016 0.005 DBMET01738 0.015 0.005 DBMET01739 | DBMET01738 | |
| 0.071 | 0.061 | 0.078 | GABA aminotransferase inhibitor | 0.078 0.049 DBMET01738 | DBMET01738 | |
| 0.048 | 0.039 | 0.048 | Dihydroorotate dehydrogenase inhibitor | 0.046 0.042 DBMET01738 | ||
| 0.047 | 0.038 | 0.047 | CC chemokine receptor 2B antagonist | |||
| 0.027 | 0.018 | 0.027 | Myristoyl transferase inhibitor | |||
| 0.048 | 0.039 | 0.048 | Phosphatidylinositol 3-kinase alpha inhibitor | |||
| 0.026 | 0.018 | 0.026 | Complement factor 1r inhibitor | |||
| 0.078 | 0.071 | 0.078 | Transforming growth factor beta 3 antagonist | |||
| 0.075 | 0.067 | 0.075 | Neuropeptide Y antagonist | |||
| 0.056 | 0.05 | 0.056 | Potassium channel intermediate-conductance Ca-activated blocker | 0.056 0.05 DBMET01740 | ||
| 0.05 | 0.044 | 0.05 | Carbonic anhydrase II inhibitor | |||
| 0.081 | 0.075 | 0.081 | Pim-3 kinase inhibitor | |||
| 0.067 | 0.062 | 0.067 | Peroxisome proliferator-activated receptor gamma antagonist | |||
| 0.039 | 0.036 | 0.039 | Histamine H2 receptor agonist | |||
| 0.041 | 0.037 | 0.041 | Dihydroorotase inhibitor | |||
| 0.03 | 0.028 | 0.03 | Calcium release-activated channel blocker | |||
| 0.174 | 0.171 | 0.384 | Lipoxygenase inhibitor | 0.283 0.08 DBMET01737 0.241 0.106 DBMET01738 0.384 0.042 DBMET01740 | DBMET01740 | |
| 0.021 | 0.019 | 0.021 | Dopamine autoreceptor agonist | |||
| 0.053 | 0.052 | 0.053 | Carbonic anhydrase inhibitor | |||
| 0.031 | 0.03 | 0.033 | Protein kinase (CK2) beta inhibitor | 0.033 0.023 DBMET01738 | DBMET01738 | |
| 0.055 | 0.055 | 0.059 | Enoyl-[acyl-carrier-protein] reductase inhibitor | 0.059 0.046 DBMET01738 | DBMET01738 | |
| 0.04 | 0.04 | 0.047 | Carbonic anhydrase VII inhibitor | 0.047 0.032 DBMET01738 | DBMET01738 | |
| 0.114 | 0.114 | 0.123 | Dual specificity tyrosine-phosphorylation regulated kinase 1B inhibitor | 0.123 0.103 DBMET01738 | DBMET01738 | |
| 0.046 | 0.046 | 0.144 | Alpha tubulin antagonist | 0.049 0.043 DBMET01737 0.144 0.01 DBMET01738 0.066 0.027 DBMET01739 | DBMET01738 | |
| 0.073 | 0.076 | 0.084 | Alpha 2 adrenoreceptor antagonist | 0.084 0.061 DBMET01738 | DBMET01738 | |
| 0.128 | 0.13 | 0.13 | Ca2+-transporting ATPase inhibitor | 0.13 0.118 DBMET01737 0.13 0.118 DBMET01738 | DBMET01738 | |
| 0.053 | 0.055 | 0.092 | Heat shock protein 90 beta antagonist | 0.077 0.023 DBMET01737 0.092 0.014 DBMET01738 0.091 0.014 DBMET01739 | DBMET01738 | |
| 0.044 | 0.047 | 0.046 | Dopamine beta hydroxylase inhibitor | 0.046 0.04 DBMET01738 0.045 0.043 DBMET01739 | DBMET01738 | |
| 0.184 | 0.187 | 0.209 | 5 Hydroxytryptamine uptake stimulant | 0.207 0.139 DBMET01738 0.209 0.135 DBMET01739 | DBMET01739 | |
| 0.034 | 0.037 | 0.053 | Estradiol 17 beta-dehydrogenase inhibitor | 0.053 0.023 DBMET01738 | DBMET01738 | |
| 0.061 | 0.067 | 0.08 | Histone deacetylase stimulant | 0.08 0.044 DBMET01738 | DBMET01738 | |
| 0.061 | 0.067 | 0.08 | Histone deacetylase SIRT1 stimulant | 0.08 0.044 DBMET01738 | DBMET01738 | |
| 0.088 | 0.093 | 0.091 | Adenylate kinase inhibitor | 0.091 0.084 DBMET01739 | DBMET01739 | |
| 0.047 | 0.055 | 0.055 | Sphingosine kinase 2 inhibitor | 0.055 0.038 DBMET01737 | DBMET01737 | |
| 0.076 | 0.085 | 0.083 | NADH dehydrogenase inhibitor | 0.08 0.075 DBMET01737 0.083 0.068 DBMET01739 | DBMET01739 | |
| 0.076 | 0.088 | 0.085 | Granulocyte macrophage colony stimulating factor agonist | 0.085 0.062 DBMET01738 0.08 0.076 DBMET01739 | DBMET01738 | |
| 0.081 | 0.093 | 0.09 | GABA C receptor agonist | 0.09 0.078 DBMET01737 0.09 0.078 DBMET01738 0.09 0.078 DBMET01739 | DBMET01739 | |
| 0.083 | 0.096 | 0.12 | Estrogen receptor beta antagonist | 0.12 0.031 DBMET01737 0.115 0.038 DBMET01738 0.09 0.083 DBMET01740 | DBMET01737 | |
| 0.094 | 0.108 | 0.221 | Tubulin antagonist | 0.221 0.031 DBMET01738 0.121 0.079 DBMET01739 | DBMET01738 | |
| 0.103 | 0.119 | 0.108 | DNA repair enzyme inhibitor | 0.108 0.102 DBMET01738 | DBMET01738 | |
| 0.046 | 0.065 | 0.052 | Dihydroorotate oxidase inhibitor | 0.052 0.046 DBMET01737 0.05 0.049 DBMET01738 | DBMET01737 | |
| 0.058 | 0.078 | 0.073 | Alpha 2a adrenoreceptor antagonist | 0.073 0.055 DBMET01738 | DBMET01738 | |
| 0.081 | 0.1 | 0.12 | Protein kinase (CK2) alpha inhibitor | 0.114 0.066 DBMET01738 0.12 0.062 DBMET01739 | DBMET01739 | |
| 0.165 | 0.189 | 0.245 | 12-Lipoxygenase inhibitor | 0.236 0.117 DBMET01737 0.245 0.112 DBMET01738 | DBMET01738 | |
| 0.164 | 0.189 | 0.192 | Transcription factor STAT3 inhibitor | 0.192 0.145 DBMET01739 | DBMET01739 | |
| 0.034 | 0.062 | 0.038 | CF transmembrane conductance regulator antagonist | 0.038 0.035 DBMET01739 | DBMET01739 | |
| 0.067 | 0.097 | 0.118 | Hepatocyte growth factor antagonist | 0.081 0.073 DBMET01738 0.118 0.036 DBMET01739 | DBMET01739 | |
| 0.052 | 0.082 | 0.075 | Carbonic anhydrase XIII inhibitor | 0.075 0.054 DBMET01738 | DBMET01738 | |
| 0.155 | 0.186 | 0.212 | RNA-directed DNA polymerase inhibitor | 0.178 0.137 DBMET01737 0.212 0.083 DBMET01738 0.183 0.128 DBMET01739 | DBMET01738 | |
| 0.007 | 0.039 | 0.017 | Human herpes virus 5 capsid protein P40 inhibitor | 0.017 0.005 DBMET01740 | DBMET01740 | |
| 0.028 | 0.061 | 0.086 | Proto-oncogene tyrosine-protein kinase Met inhibitor | 0.086 0.014 DBMET01739 | DBMET01739 | |
| 0.113 | 0.153 | 0.348 | Dual specificity phosphatase inhibitor | 0.348 0.021 DBMET01737 0.164 0.08 DBMET01738 0.227 0.044 DBMET01739 | DBMET01737 | |
| 0.034 | 0.079 | 0.052 | Beta 1 adrenoreceptor antagonist | 0.052 0.044 DBMET01739 | DBMET01739 | |
| 0.03 | 0.077 | 0.041 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.041 0.03 DBMET01737 | DBMET01737 | |
| 0.055 | 0.101 | 0.067 | Metalloproteinase-9 inhibitor | 0.067 0.061 DBMET01740 | DBMET01740 | |
| 0.063 | 0.11 | 0.115 | Vascular endothelial growth factor 1 antagonist | 0.115 0.057 DBMET01739 | DBMET01739 | |
| 0.039 | 0.089 | 0.073 | Collagenase 3 inhibitor | 0.073 0.029 DBMET01740 | DBMET01740 | |
| 0.03 | 0.081 | 0.048 | Beta 2 adrenoreceptor antagonist | 0.048 0.039 DBMET01737 | DBMET01737 | |
| 0.058 | 0.113 | 0.073 | Estrogen receptor alpha antagonist | 0.073 0.061 DBMET01737 | DBMET01737 | |
| 0.16 | 0.215 | 0.242 | Ca2+/calmodulin-dependent kinase II alpha inhibitor | 0.242 0.114 DBMET01737 0.228 0.128 DBMET01738 | DBMET01737 | |
| 0.035 | 0.094 | 0.049 | Glucose-6-phosphate translocase inhibitor | 0.049 0.04 DBMET01738 | DBMET01738 | |
| 0.065 | 0.127 | 0.142 | Vascular endothelial growth factor antagonist | 0.142 0.058 DBMET01739 | DBMET01739 | |
| 0.125 | 0.19 | 0.166 | Proto-oncogene tyrosine-protein kinase Fyn inhibitor | 0.166 0.111 DBMET01738 | DBMET01738 | |
| 0.021 | 0.086 | 0.038 | Dopamine D5 agonist | 0.038 0.031 DBMET01738 | DBMET01738 | |
| 0.049 | 0.117 | 0.082 | Proto-oncogene tyrosine-protein kinase Kit inhibitor | 0.082 0.07 DBMET01738 | DBMET01738 | |
| 0.053 | 0.125 | 0.129 | Vascular endothelial growth factor 2 antagonist | 0.129 0.056 DBMET01739 | DBMET01739 | |
| 0.158 | 0.232 | 0.185 | Tyrosine 3 hydroxylase inhibitor | 0.185 0.165 DBMET01739 | DBMET01739 | |
| 0.053 | 0.137 | 0.539 | 5-Lipoxygenase inhibitor | 0.101 0.063 DBMET01737 0.109 0.057 DBMET01738 0.539 0.004 DBMET01740 | DBMET01740 | |
| 0.061 | 0.161 | 0.088 | Xanthine oxidase inhibitor | 0.088 0.075 DBMET01737 | DBMET01737 | |
| 0.043 | 0.147 | 0.092 | Monophenol monooxygenase inhibitor | 0.092 0.082 DBMET01737 0.092 0.082 DBMET01738 | DBMET01738 | |
| 0.103 | 0.209 | 0.142 | Death-associated protein kinase 3 inhibitor | 0.142 0.136 DBMET01739 | DBMET01739 | |
| 0.093 | 0.204 | 0.125 | Adenylate cyclase stimulant | 0.125 0.114 DBMET01738 | DBMET01738 | |
| 0.033 | 0.15 | 0.065 | Glutamate decarboxylase inhibitor | 0.065 0.061 DBMET01738 | DBMET01738 | |
| 0.075 | 0.199 | 0.146 | Mcl-1 antagonist | 0.146 0.093 DBMET01738 | DBMET01738 | |
| 0.058 | 0.187 | 0.439 | Cyclooxygenase 1 inhibitor | 0.439 0.005 DBMET01740 | DBMET01740 | |
| 0.129 | 0.272 | 0.225 | Angiogenesis inhibitor | 0.21 0.158 DBMET01738 0.225 0.143 DBMET01739 | DBMET01739 | |
| 0.026 | 0.176 | 0.05 | CXC chemokine 1 receptor antagonist | 0.05 0.037 DBMET01737 | DBMET01737 | |
| 0.092 | 0.244 | 0.305 | Free radical scavenger | 0.226 0.08 DBMET01737 0.305 0.05 DBMET01738 0.179 0.115 DBMET01739 | DBMET01738 | |
| 0.067 | 0.22 | 0.167 | Protein-tyrosine phosphatase inhibitor | 0.167 0.064 DBMET01737 | DBMET01737 | |
| 0.042 | 0.203 | 0.083 | Creatine kinase inhibitor | 0.083 0.081 DBMET01738 | DBMET01738 | |
| 0.101 | 0.269 | 0.12 | CC chemokine 6 receptor antagonist | 0.12 0.115 DBMET01738 | DBMET01738 | |
| 0.056 | 0.226 | 0.395 | Cyclooxygenase inhibitor | 0.395 0.008 DBMET01740 | DBMET01740 | |
| 0.044 | 0.23 | 0.37 | Cyclooxygenase 2 inhibitor | 0.37 0.007 DBMET01740 | DBMET01740 | |
| 0.071 | 0.261 | 0.205 | Antimitotic | 0.205 0.081 DBMET01738 | DBMET01738 | |
| 0.058 | 0.265 | 0.125 | Interleukin 4 antagonist | 0.125 0.079 DBMET01738 | DBMET01738 | |
| 0.052 | 0.274 | 0.195 | Amyloid beta aggregation inhibitor | 0.187 0.085 DBMET01737 0.195 0.081 DBMET01738 | DBMET01738 | |
| 0.065 | 0.288 | 0.13 | DNA methyltransferase I inhibitor | 0.13 0.129 DBMET01738 | DBMET01738 | |
| 0.033 | 0.27 | 0.399 | Glutamate receptor antagonist | 0.399 0.005 DBMET01740 | DBMET01740 | |
| 0.007 | 0.247 | 0.053 | Beta tubulin antagonist | 0.053 0.044 DBMET01738 | DBMET01738 | |
| 0.038 | 0.313 | 0.144 | Growth factor antagonist | 0.144 0.074 DBMET01739 | DBMET01739 | |
| 0.036 | 0.323 | 0.094 | Falcipain 2 inhibitor | 0.094 0.057 DBMET01739 | DBMET01739 | |
| 0.035 | 0.332 | 0.094 | Falcipain inhibitor | 0.094 0.059 DBMET01739 | DBMET01739 | |
| 0.005 | 0.315 | 0.029 | Histone deacetylase 1 inhibitor | 0.029 0.015 DBMET01740 | DBMET01740 | |
| 0.005 | 0.356 | 0.067 | Histone deacetylase 5 inhibitor | 0.067 0.013 DBMET01740 | DBMET01740 | |
| 0.024 | 0.412 | 0.104 | Chelator | 0.104 0.072 DBMET01737 | DBMET01737 | |
| 0.04 | 0.469 | 0.21 | Antioxidant | 0.21 0.107 DBMET01738 | DBMET01738 | |
| 0.005 | 0.476 | 0.037 | Histone deacetylase 2 inhibitor | 0.037 0.02 DBMET01740 | DBMET01740 | |
| 0.004 | 0.486 | 0.047 | Histone deacetylase class IIa inhibitor | 0.047 0.015 DBMET01740 | DBMET01740 | |
| 0.064 | 0.586 | 0.24 | Apoptosis agonist | 0.24 0.226 DBMET01738 | DBMET01738 | |
| 0.004 | 0.644 | 0.027 | Dopamine D1 agonist | 0.027 0.01 DBMET01739 | DBMET01739 | |
| 0.004 | 0.695 | 0.029 | Histone deacetylase class IV inhibitor | 0.029 0.024 DBMET01740 | DBMET01740 | |
| 0.004 | 0.695 | 0.029 | Histone deacetylase 11 inhibitor | 0.029 0.024 DBMET01740 | DBMET01740 | |
| 0.004 | 0.749 | 0.049 | Histone deacetylase class II inhibitor | 0.049 0.012 DBMET01740 | DBMET01740 | |
| 0.003 | 0.862 | 0.036 | Histone deacetylase 6 inhibitor | 0.036 0.014 DBMET01740 | DBMET01740 | |
| 0.003 | 0.863 | 0.036 | Histone deacetylase class IIb inhibitor | 0.036 0.014 DBMET01740 | DBMET01740 | |
| 0.006 | 0.882 | 0.031 | ADAM10 endopeptidase inhibitor | 0.031 0.029 DBMET01740 | DBMET01740 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |